» Articles » PMID: 29048513

Sepsis National Hospital Inpatient Quality Measure (SEP-1): Multistakeholder Work Group Recommendations for Appropriate Antibiotics for the Treatment of Sepsis

Overview
Journal Clin Infect Dis
Date 2017 Oct 20
PMID 29048513
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The Center for Medicare and Medicaid Services adopted the Early Management Bundle, Severe Sepsis/Septic Shock (SEP-1) performance measure to the Hospital Inpatient Quality Reporting Program in July 2015 to help address the high mortality and high cost associated with sepsis. The SEP-1 performance measure requires, among other critical interventions, timely administration of antibiotics to patients with sepsis or septic shock. The multistakeholder workgroup recognizes the need for SEP-1 but strongly believes that multiple antibiotics listed in the antibiotic tables for SEP-1 are not appropriate and the use of these antibiotics, as called for in the SEP-1 measure, is not in alignment with prudent antimicrobial stewardship. To promote the appropriate use of antimicrobials and combat antimicrobial resistance, the workgroup provides recommendations for appropriate antibiotics for the treatment of sepsis.

Citing Articles

A comparison of empiric therapy with cefazolin versus ceftriaxone for patients with complicated urinary tract infections in a tertiary care veterans affairs medical center.

Carcamo P, Walter E, Frei C, Yang L, Cadena J, Hopkins T BMC Infect Dis. 2025; 25(1):302.

PMID: 40033251 PMC: 11874385. DOI: 10.1186/s12879-025-10494-5.


Impact of Appropriate Empirical Antibiotic Treatment on the Clinical Response of Septic Patients in Intensive Care Unit: A Single-Center Observational Study.

Ticac M, Grubic Kezele T, Bubonja Sonje M Antibiotics (Basel). 2024; 13(6).

PMID: 38927235 PMC: 11201024. DOI: 10.3390/antibiotics13060569.


Rapid diagnosis of bloodstream infections using a culture-free phenotypic platform.

Shi X, Sharma S, Chmielewski R, Markovic M, VanEpps J, Yau S Commun Med (Lond). 2024; 4(1):77.

PMID: 38654117 PMC: 11039749. DOI: 10.1038/s43856-024-00487-x.


Multidrug-Resistant Sepsis: A Critical Healthcare Challenge.

Kumar N, Balraj T, Kempegowda S, Prashant A Antibiotics (Basel). 2024; 13(1).

PMID: 38247605 PMC: 10812490. DOI: 10.3390/antibiotics13010046.


The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).

Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T Acute Med Surg. 2021; 8(1):e659.

PMID: 34484801 PMC: 8390911. DOI: 10.1002/ams2.659.